Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Multiple sclerosis: genetics, biomarkers, treatments.
Bioinformatics challenges for genome-wide association studies.
β-Lapachone ameliorization of experimental autoimmune encephalomyelitis.
Changes in Fatigue and Cognition in Patients with Relapsing Forms of Multiple Sclerosis Treated with Natalizumab: The ENER-G Study.
The Transcription Factor IRF8 Activates Integrin-Mediated TGF-β Signaling and Promotes Neuroinflammation.
The role of microglial activation in disease progression.
Compassionate Use Programme Update
In vivo identification of morphologic retinal abnormalities in neuromyelitis optica.
Management of Spasticity in Progressive Multiple Sclerosis: Efficacy of Repeated Intrathecal Triamcinolone Acetonide Administration.
ER Chaperone BiP/GRP78 Is Required for Myelinating Cell Survival and Provides Protection during Experimental Autoimmune Encephalomyelitis.
The role of interleukin-6 signaling in nervous tissue.
Acute disseminated encephalomyelitis after tetanus vaccination of a pregnant woman in Senegal.
AP-1 Mediated Transcriptional Repression of Matrix Metalloproteinase-9 by Recruitment of Histone Deacetylase 1 in Response to Interferon β.
[Levels of Beclin 1 and LC3 in peripheral blood mononuclear cells of patients with multiple sclerosis and neuromyelitis optica and its significance].
Evaluation of the effectiveness of home based or hospital based calisthenic exercises in patients with multiple sclerosis.
Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial
Assessment of neuroactive steroids in cerebrospinal fluid comparing acute relapse and stable disease in relapsing-remitting multiple sclerosis.
Physical fitness assessment in multiple sclerosis patients: A controlled study.
Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis. (MOBILE)
Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial.
Ten-year prognosis in multiple sclerosis: a better outcome in relapsing-remitting patients but not in primary progressive patients.
Future clinical challenges in multiple sclerosis: Relevance to sphingosine 1-phosphate receptor modulator therapy.
Natural, innate improvements in multiple sclerosis disability.
Tract-based spatial statistics analysis of diffusion-tensor imaging data in pediatric- and adult-onset multiple sclerosis.
Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review.

Pages